A protein delivery system: biodegradable alginate-chitosan-poly(lactic-co-glycolic acid) composite microspheres

被引:112
作者
Zheng, CH
Gao, JQ
Zhang, YP
Liang, WQ [1 ]
机构
[1] Zhejiang Univ, Dept Pharmaceut, Coll Pharmaceut Sci, Hangzhou 310031, Peoples R China
[2] Zhejiang Univ, Obstet & Gynecol Hosp, Hangzhou 310006, Peoples R China
基金
中国国家自然科学基金;
关键词
microspheres; poly(lactic-co-glycolic acid); alginate; chitosan; bovine serum albumin;
D O I
10.1016/j.bbrc.2004.09.007
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In the present study we developed alginate-chitosan-poly(lactic-co-glycolic acid) (PLGA) composite microspheres to elevate protein entrapment efficiency and decrease its burst release. Bovine serum albumin (BSA), which used as the model protein, was entrapped into the alginate microcapsules by a modified emulsification method in an isopropyl alcohol-washed way. The rapid drug releases were sustained by chitosan coating. To obtain the desired release properties, the alginate-chitosan microcapsules were further incorporated in the PLGA to form the composite microspheres. The average diameter of the composite microcapsules was 31 +/- 9 mum and the encapsulation efficiency was 81-87%, while that of conventional PLGA microspheres was just 61-65%. Furthermore, the burst releases at 1 h of BSA entrapped in composite microspheres which containing PLGA (50:50) and PLGA (70:30) decreased to 24% and 8% in PBS, and further decreased to 51% and 2% in saline. On the contrary, the burst releases of conventional PLGA microspheres were 48% and 52% in PBS, respectively. Moreover, the release profiles could be manipulated by regulating the ratios of poly(lactic acid) to poly(glycolic acid) in the composite microspheres. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:1321 / 1327
页数:7
相关论文
共 26 条
[1]   Biodegradation and biocompatibility of PLA and PLGA microspheres [J].
Anderson, JM ;
Shive, MS .
ADVANCED DRUG DELIVERY REVIEWS, 1997, 28 (01) :5-24
[2]   Protein encapsulation and release from poly(lactide-co-glycolide) microspheres: effect of the protein and polymer properties and of the co-encapsulation of surfactants [J].
Blanco, D ;
Alonso, MJ .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 1998, 45 (03) :285-294
[3]   Encapsulation-induced aggregation and loss in activity of γ-chymotrypsin and their prevention [J].
Castellanos, IJ ;
Cruz, G ;
Crespo, R ;
Griebenow, K .
JOURNAL OF CONTROLLED RELEASE, 2002, 81 (03) :307-319
[4]   Preparation and characterization of fentanyl-loaded PLGA microspheres: in vitro release profiles [J].
Choi, HS ;
Seo, SA ;
Khang, G ;
Rhee, JM ;
Lee, HB .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 234 (1-2) :195-203
[5]   Stabilization of recombinant interferon-α by pegylation for encapsulation in PLGA microspheres [J].
Diwan, M ;
Park, TG .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2003, 252 (1-2) :111-122
[6]   Pegylation enhances protein stability during encapsulation in PLGA microspheres [J].
Diwan, M ;
Park, TG .
JOURNAL OF CONTROLLED RELEASE, 2001, 73 (2-3) :233-244
[7]   In vitro evaluation of alginate beads of a diclofenac salt [J].
Fernandez-Hervas, MJ ;
Holgado, MA ;
Fini, A ;
Fell, JT .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1998, 163 (1-2) :23-34
[8]   Alginate/chitosan particulate systems for sodium diclofenac release [J].
González-Rodríguez, ML ;
Holgado, MA ;
Sánchez-Lafuente, C ;
Rabasco, AM ;
Fini, A .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 232 (1-2) :225-234
[9]   Size dependent immune response after subcutaneous, oral and intranasal administration of BSA loaded nanospheres [J].
Gutierro, I ;
Hernández, RM ;
Igartua, M ;
Gascón, AR ;
Pedraz, JL .
VACCINE, 2002, 21 (1-2) :67-77
[10]   The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices [J].
Jain, RA .
BIOMATERIALS, 2000, 21 (23) :2475-2490